FDA Clearance Tracker · P250015
PerQseal® Elite Vascular Closure Device
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Oct 16, 2026
Approved
Time to decision
487 days
Received Jun 16, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P250015
- Device name
- PerQseal® Elite Vascular Closure Device
- Applicant
- Vivasure Medical , Ltd.
- Applicant location
- Galway
- Received
- Jun 16, 2025
- Decided
- Oct 16, 2026
- Decision
- Approved
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the PerQSeal Elite Vascular Closure Device. The device is indicated for the percutaneous closure of common femoral arteriotomies in patients following interventional endovascular catheterization procedures utilizing 14 22 F sheaths (arteriotomies up to 26 F).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MGB. The earliest in FDA's data is P920004, decided Sep 29, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Vivasure Medical , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.